Baidu
map

肿瘤指南

订阅

MedSci主页 / 所有栏目 / 肿瘤指南

2021 MASCC 晚期癌症止吐药更新指南

2021-08-16 癌症支持疗法多国学会 Supportive Care in Cancer

癌症止吐药

恶心和呕吐是晚期癌症患者的常见临床症状。药物管理很重要。需要药物选择和指南的证据来帮助临床医生控制该人群的恶心和呕吐。

中文标题：

2021 MASCC 晚期癌症止吐药更新指南

发布机构：

癌症支持疗法多国学会

发布日期：

2021-08-16

简要介绍：

恶心和呕吐是晚期癌症患者的常见临床症状。药物管理很重要。需要药物选择和指南的证据来帮助临床医生控制该人群的恶心和呕吐。

相关资料下载：
[AttachmentFileName(sort=1, fileName=MASCC 晚期癌症止吐药更新指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=482f71c0022955c1, title=2021 MASCC 晚期癌症止吐药更新指南, enTitle=, guiderFrom=Supportive Care in Cancer, authorId=0, author=, summary=恶心和呕吐是晚期癌症患者的常见临床症状。药物管理很重要。需要药物选择和指南的证据来帮助临床医生控制该人群的恶心和呕吐。, cover=https://img.medsci.cn/20211219/1639882497920_5579292.png, journalId=0, articlesId=null, associationId=993, associationName=癌症支持疗法多国学会, associationIntro=MASCC是癌症支持疗法多国学会的缩写，是一涉及癌症支持疗法的多学科的国际性组织。成员来自各大洲的60多个国家。MASCC成立于1990年，该组织致力于对各期癌症病人支持疗法各个方面的研究及教育。MASCC的工作目标是通过研究及科学认识的交流，提高支持疗法的专业水平。, copyright=0, guiderPublishedTime=Mon Aug 16 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">恶心和呕吐是晚期癌症患者的常见临床症状。</span><span style="color: #333333;">药物管理很重要。</span><span style="color: #333333;">需要药物选择和指南的证据来帮助临床医生控制该人群的恶心和呕吐。</span></p>, tagList=[TagDto(tagId=120030, tagName=癌症止吐药)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1255, guiderKeyword=止吐药, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3809, appHits=84, showAppHits=0, pcHits=850, showPcHits=3719, likes=0, shares=10, comments=4, approvalStatus=1, publishedTime=Sun Dec 19 10:50:34 CST 2021, publishedTimeString=2021-08-16, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Sun Dec 19 11:00:06 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 13:56:40 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=MASCC 晚期癌症止吐药更新指南.pdf)])
MASCC 晚期癌症止吐药更新指南.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1188641, encodeId=cb401188641d3, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf6d5619254, createdName=ms1000000413528422, createdTime=Thu Jan 27 18:35:30 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181085, encodeId=29c0118108510, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5083061900, createdName=1772a32f60m, createdTime=Wed Jan 05 22:40:02 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082344, encodeId=3aec108234467, content=学习好指南，让癌症患者更舒适, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9e64673439, createdName=362892879, createdTime=Tue Dec 21 08:31:21 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082323, encodeId=314c10823237e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Dec 21 07:03:19 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2022-01-27 ms1000000413528422

    好好学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1188641, encodeId=cb401188641d3, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf6d5619254, createdName=ms1000000413528422, createdTime=Thu Jan 27 18:35:30 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181085, encodeId=29c0118108510, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5083061900, createdName=1772a32f60m, createdTime=Wed Jan 05 22:40:02 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082344, encodeId=3aec108234467, content=学习好指南，让癌症患者更舒适, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9e64673439, createdName=362892879, createdTime=Tue Dec 21 08:31:21 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082323, encodeId=314c10823237e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Dec 21 07:03:19 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2022-01-05 1772a32f60m

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1188641, encodeId=cb401188641d3, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf6d5619254, createdName=ms1000000413528422, createdTime=Thu Jan 27 18:35:30 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181085, encodeId=29c0118108510, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5083061900, createdName=1772a32f60m, createdTime=Wed Jan 05 22:40:02 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082344, encodeId=3aec108234467, content=学习好指南，让癌症患者更舒适, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9e64673439, createdName=362892879, createdTime=Tue Dec 21 08:31:21 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082323, encodeId=314c10823237e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Dec 21 07:03:19 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2021-12-21 362892879

    学习好指南，让癌症患者更舒适

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1188641, encodeId=cb401188641d3, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf6d5619254, createdName=ms1000000413528422, createdTime=Thu Jan 27 18:35:30 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181085, encodeId=29c0118108510, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5083061900, createdName=1772a32f60m, createdTime=Wed Jan 05 22:40:02 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082344, encodeId=3aec108234467, content=学习好指南，让癌症患者更舒适, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9e64673439, createdName=362892879, createdTime=Tue Dec 21 08:31:21 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082323, encodeId=314c10823237e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Dec 21 07:03:19 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2021-12-21 微探

    学习学习

    0

Baidu
map
Baidu
map
Baidu
map